Continuous intravenous infusion of a low-molecular-weight heparin during allogenic haematopoietic stem-cell transplantation

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 7, 2008, Pages 735-737

  Boeras, Anca ^a   Lambert, Catherine ^a   Ferrant, Augustin ^a   Van Den Neste, Eric ^a   Hermans, Cedric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anti Xa activity; Continuous infusion; Low molecular weight heparins

Indexed keywords

ACENOCOUMAROL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; NADROPARIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTICOAGULATION; AORTA VALVE; ARTICLE; BLEEDING; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ACUTE DISEASE; ANTICOAGULANTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, MYELOID; MIDDLE AGED; NADROPARIN;

EID: 55049119718     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32830b14de     Document Type: Article

References (6)

1. Bernardi E, Prandoni P. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism. Curr Opin Pulm Med 2005; 11:363-367.
2. De Vos JY, Marzoughi H, Hombrouckx R. Heparinisation in chronic haemodialysis treatment: bolus injection or continuous homogeneous infusion? EDTNA ERCA J 2000; 26:20-21.
3. Guillet B, Simon N, Sampol JJ, Lorec-Penet AM, Portugal H, Berland Y, et al. Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h affer bolus administration as an anticoagulant in haemodialysis. Nephrol Dial Transplant 2003; 18:2348-2353.
4. Ibbotson T, Goa KL. Enoxaparin: an update of its clinical use in the management of acute coronary syndromes. Drugs 2002; 62:1407-1430.
5. Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006; 144:673-684.
6. Kane-Gill SL, Feng Y, Bobek MB, Bies RR, Pruchnicki MC, Dasta JF. Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety. J Clin Pharm Ther 2005; 30:207-213.